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ABSTRACT
The present review provides an update 
of the available data and discusses re-
search issues of ultrasound (US) imag-
ing in rheumatoid arthritis (RA).
Currently the principal indications for 
using US in the assessment of patients 
with RA include: detection of sub-clini-
cal synovitis, demonstration of bone 
erosion undetected by conventional 
radiography, detailed assessment of 
tendon pathology and guided injection 
and aspiration of joints and soft tis-
sues. Future potential applications are 
likely to include short and long term 
therapy monitoring and early detection 
of cartilaginous changes in RA.
The main priorities requiring the atten-
tion of investigators include: address-
ing validity issues, especially those 
related to criterion and discriminator 
validity, development of international 
consensus on scoring systems, evalua-
tion of the role of power Doppler in the 
assessment of disease activity, develop-
ment of a specific training programme 
for rheumatologists performing US and 
investigation of the potential of 3D US 
using a volumetric probe.
Introduction
Over the last decade, there has been an 
explosion of research in the field of the 
management of patients with rheuma-
toid arthritis (RA). Refining diagnos-
tic accuracy in early disease, intensive 
monitoring of disease activity and the 
search for the ideal therapy leading to 
remission have been the key targets of 
these investigations (1-3).
Ultrasound (US) is rapidly becoming 
one of the standard tools within the 
rheumatologistʼs armamentarium in the 
assessment of patients with RA.
Despite the enormous advances of the 
last decade, US imaging continues to 
evolve both in terms of technological 
advancement and the ever increasing 
number of applications in rheumatolo-
gy (4-7). Over the last five years, there 
has been exponential growth within the 
literature, centring upon the US assess-
ment of patients with RA (8-18).
This review provides an update of the 
available data and discusses research 
issues of US imaging in RA.
Clinical applications
Currently the principal indications for 
using US in the assessment of patients 
with RA include: detection of sub-clin-
ical synovitis, demonstration of bone 
erosion undetected by conventional 
radiography, detailed assessment of 
tendon pathology and guided injection 
and aspiration of joints and soft tissues 
(19-23). These applications have been 
collated by an international panel of 
experts in US, both rheumatologists 
and radiologists, and represent part of 
the core knowledge and skills required 
for competency in musculoskeletal US 
(20).
Future potential applications are likely 
to include short and long term therapy 
monitoring and early detection of carti-
laginous changes in RA.
Greyscale US with high quality equip-
ment permits quick and accurate dif-
ferentiation between synovial effusion 
and synovial proliferation (19, 24). 
Power Doppler provides information 
on the perfusional status of the syno-
vial tissue which reflects the activity of 
the inflammatory process (25-27).
Moreover, US is helpful in identifying 
pathologic changes responsible for re-
gional pain syndromes in patients with 
RA e.g., shoulder pain, carpal tunnel 
syndrome, knee pain (28-31).
The use of high frequency US to guide 
needle positioning within inflamed 
small joints of the hand, has been 
shown to provide greater accuracy than 
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Table I. Pathologic conditions and corresponding US findings.
Pathologic US findings
condition 
Joint effusion Anechoic homogeneous joint space widening (4).
 An intra-articular black, anechoic area (8).
 A compressible anechoic intra-capsular area (10).
 A hypoechoic or anechoic compressible intra-articular material, within synovial re-
cesses (13).
 The presence of an abnormally anechoic space within the joint, which was compress-
ible (21).
 Anechoic joint space widening (28).
Synovitis Homogeneous echoic joint space widening indicating synovial proliferation appear-
ing as irregular clusters of soft echoes (4).
 A thickening of the synovial membrane (synovial proliferation) was visualised by US 
as hypo- or hyperechoic structures within the region affected by effusion (8).
 A non-compressible hypoechoic intracapsular area (10).
 An echogenic non-compressible intra-articular tissue, within synovial recesses (13).
 The presence of an abnormally hypoechoic joint space reflecting synovial hypertro-
phy, distinct from the intra-articular fat pad and non-compressible with the transducer 
(21).
 Joint space widening with clusters of soft echoes (bushy and villous appearance) and/
or homogeneous synovial thickening (28).
Bone erosion An interruption of the bone surface visible in two planes (8).
 Change in the bone surface of the area adjacent to the joint (10).
 A cortical defect seen in two or more scanning planes (21).
 An intra-articular discontinuity of the bone surface that is visible in 2 perpendicular 
planes (36).
 A cortical “break” or defect with an irregular floor seen in longitudinal and transverse 
planes (41).
 An interruption of the bone margin (42).
Tenosynovitis Tendon sheath widening resulting from effusion (anechoic pattern), proliferative syn-
ovitis (echoic pattern) or both (mixed pattern) (4, 22).
 Abnormally hypoechoic area around tendon seen in longitudinal and transverse planes 
(21).
 Homogeneous hypo- or anechoic tendon sheath wideing (exudative tenosynovitis) 
(30).
 Tendon sheath widening due to an irregular thickening of the synovial tissue (prolif-
erative tenosynovitis) (30).
 Hypoechoic or anechoic thickened tissue with or without fluid within the tendon 
sheath, which is seen in 2 perpendicular planes and which may exhibit Doppler signal 
(36).
 Presence of fluid within the tendon sheath, thickening of the tendon sheath, thickening 
of the tendon (43).
Tendon rupture Discontinuity of the tendon visualised with the ultrasound beam exactly perpendicular 
to the tendon (22).
 Tendon tears appear as fragmentation of small groups of contiguous fibrils, which 
determines a characteristic loss of the normal fibrillar echotexture of the tendon (30).
the palpation guided approach (96% v 
59%) (32).
Similarly, using US guidance the risk 
of damaging tendons, nerves, blood 
vessels and cartilage is significantly re-
duced (33-35).
Sonographic findings
The main pathological features detect-
ed by US in patients with RA are those 
related to synovial tissue inflammation 
and joint damage (Table I) (Fig. 1). 
Joint effusion and synovial prolifera-
tion result in joint cavity widening of 
various extent. Preliminary definitions 
of both synovial fluid and synovial pro-
liferation have been recently provided 
by the Outcome Measures in Rheuma-
toid Arthritis Clinical Trials (OMER-
ACT) Special Interest Group for mus-
culoskeletal US in Rheumatology (36). 
Real time examination is the most reli-
able method of scanning to distinguish 
between synovial fluid and prolifera-
tion. Synovial fluid is compressible and 
displaceable whereas synovial tissue is 
not. Further differentiation is provided 
by power Doppler signal whose detec-
tion within the joint cavity indicates 
blood flow at synovial tissue level. 
Power Doppler signal usually has a 
patchy distribution within the joint 
cavity. Some studies have reported that 
the areas of synovial proliferation clos-
er to bone erosions and disruptions in 
cartilage are those most likely to show 
power Doppler signal (37), whilst oth-
ers suggest there is no increased blood 
flow at the areas of pannus invading the 
bone (38).
In a recent study, Naredo et al. present-
ed the US criteria for effusion/synovi-
tis for the main joints of the body along 
with the necessary information for 
probe and calliper placement to take 
the correspond measurements (13).
Bone erosions appear as interruptions 
of the bone profile that must be docu-
mented on at least two perpendicular 
scanning planes (36). Their size is cur-
rently estimated measuring the largest 
diameter between the free edges of the 
crater. The sonographic features of the 
synovial tissue filling the bone erosion 
is important for distinguishing between 
“hot” and “cold” erosions. The former 
show hypoechoic and hyperperfused 
synovial tissue lying within the erosive 
cavity whilst the latter are filled with 
fibrotic pannus which is more echo-
genic on greyscale and does not exhibit 
power Doppler signal.
Tendon sheath widening is the hallmark 
of tenosynovitis. A variable degree of 
tendon thickening can be detected in 
patients with tendinopathy. Thickening 
is often associated with reduction of the 
tendon echogenicity and intratendine-
ous power Doppler signal identifies the 
areas with increased perfusion. A ten-
don tear can be partial or complete and 
appears as a disturbance in the continu-
ity of the tendon fibrils which must be 
confirmed in at least two perpendicular 
scanning planes with the US beam per-
pendicular to the tendon direction (22).
Literature review
Validity issues have been recently 
reviewed by Ostergaard et al. (39). 
Whilst US was found to be a promis-
ing tool for use in clinical trials further 
investigation is needed to confirm its 
diagnostic value, sensitivity to change 
and predictive value.
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Fig. 1. Rheumatoid arthritis. Second metacarpophalangeal joint. Proliferative synovitis with a bone 
erosion on the radial aspect of the metacarpal head (arrows) documented on two perpendicular scan-
ning planes. Dorsal longitudinal (A) and lateral longitudinal (B) and transverse (C) views. m = meta-
carpal bone; p = proximal phalanx; * = synovial fluid; s = synovial proliferation. Images taken with a 
Logiq 9 (General Electrics Medical Systems, Milwaukee, WI) using a volumetric probe (4D16L).
For further ultrasound images, please go to www.clinexprheumatol.org
More recently further evidence has 
emerged in support of the role of US 
in early RA and therapy monitoring. 
US is a sensitive imaging tool for the 
detection of synovitis and bone ero-
sions especially in the early phases of 
the disease (40). Recent studies have 
shown that US is more sensitive than 
clinical examination in the detection of 
joint inflammation both in patients with 
early undifferentiated arthritis (21) and 
in patients with established RA (9, 13, 
17).
In a cohort of 80 patients with early (< 
12 months) oligoarthritis (< 5 joints 
with clinical synovitis), US found evi-
dence of sub-clinical disease in 51 pa-
tients (64%) and led to reclassification 
as polyarthritis in 29 patients (36%) 
(21).
US has also been compared to clinical 
examination in the detection of syno-
vitis in 60 joints of 94 consecutive RA 
patients with a mean disease duration of 
69.3 months. US found a significantly 
higher number of joints with effusion 
(mean 15.2) and synovitis (mean 14.6) 
than joint swelling detected by clinical 
examination (mean 11.5) (13).
Similar results have been demonstrated 
in the detection of synovitis at metacar-
pophalangeal and proximal interphalan-
geal joints of 40 RA patients with a me-
dian disease duration of 5 years. Of the 
480 joints assessed, 194 (40.4%) were 
found inflamed by US and 121 (25.2%) 
by clinical examination (9).
The sensitivity of US in the detection 
of bone erosions is dependant upon the 
resolution power of the US equipment 
and upon the width of the acoustic 
window. Several studies have demon-
strated that US is more sensitive than 
conventional radiography in the detec-
tion of bone erosions in the small joints 
of hands and feet (8, 9, 17, 41, 42). 
Most of these studies used magnetic 
resonance imaging (MRI) as the gold 
standard to confirm that the US find-
ings corresponded to bone erosions. In 
a recent cross-sectional study, compu-
ter tomography (CT) was used as the 
gold standard method to compare the 
sensitivity, specificity and accuracy of 
US, MRI and conventional radiography 
in the detection of bone erosions at the 
2nd to 5th metacarpophalangeal (MCP) 
joints in 17 patients with RA. This 
showed that bone erosions detected by 
both MRI and US, invisible on conven-
tional radiography, correspond to true 
erosions on CT. US detected 23% more 
erosions than conventional radiogra-
phy and was especially sensitive at the 
2nd and the 5th MCP joints because of 
the accessibility of the bone surfaces of 
those joints. At least one bone erosion 
was detected in all 17 patients by CT 
and MRI, in 15 patients by US and in 
8 patients by conventional radiography 
(23).
Data from several studies support the 
evidence that US provides the highest 
sensitivity in detecting bone erosions at 
the II MCP joint, especially in early RA 
(9, 23, 41, 42). Such impressive sensi-
tivity could not be obtained at IV MCP 
and wrist joints where the acoustic 
windows for exploring the intra-articu-
lar bone surfaces are narrow (41, 43).
Short-term monitoring with US has 
shown significant changes in joint in-
flammation after the administration of 
glucocorticoids and tumor necrosis fac-
tor α antagonists. Significant reduction 
of intra-articular power Doppler signal 
(up to 100%) has been demonstrated 
with intra-articular and intravenous 
corticosteroid therapy (44-49). Very 
short-term follow up (mean 52 hours) 
can demonstrate dramatic changes in 
synovial perfusion as assessed with 
quantitative power Doppler in a study 
conduced in 13 patients with active 
RA treated with 1000 mg intravenous 
methylprednisolone in the small joints 
of the hand. The therapeutic effect of 
injection therapy with glucocorticoid 
has been demonstrated after 2 weeks 
of therapy with sustained reduction in 
power Doppler signal (49). 
There is an increasing number of stud-
ies investigating US in biologic thera-
py monitoring (12, 50-56). Most of the 
studies show a significant reduction of 
intra-articular power Doppler signal at 
the small joints of the hands and wrists 
2-3 weeks after commencing biologic 
therapy. US has recently been used to 
attempt to discriminate between two 
treatment regimes; infliximab plus meth-
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Table II. US imaging in RA: research agenda.
To address validity issues, especially to obtain data on criterion and discriminator validity
To develop international consensus on scoring systems for assessing synovitis, tenosynovitis and bone 
erosions
To evaluate the role of US with power Doppler in the assessment of disease activity 
To develop a specific training programme for rheumatologists performing US examination of patients 
with RA
To investigate the potential of 3D US with the volumetric probe.
otrexate and methotrexate monotherapy 
in patients with early arthritis (12). The 
results of that study demonstrated that 
US assessment of synovial proliferation 
and intra-articular perfusion could dis-
criminate between the two groups af-
ter 18 weeks of treatment, with higher 
sensitivity than conventional clinical 
and laboratory evaluation including the 
numbers of tender and swollen joints 
together with ESR (12).
A recent study highlighted the sensitiv-
ity of imaging modalities, including US 
and MRI, in the detection of synovitis 
at MCP and wrist joints of the dominant 
hand in 107 RA patients with disease-
modyfing antirheumatic drug-induced 
clinical remission (16). Grey-scale US 
found evidence of synovial prolifera-
tion in 84.9% of the patients and power 
Doppler detected intra-articular signal 
in 60.4% of the patients.
Research agenda
The main priorities requiring the atten-
tion of investigators are listed in Table 
II.
Over the last few years, several scor-
ing systems have been proposed for 
assessing joint inflammation and bone 
erosions in patients with RA. The dif-
ferences between these scoring systems 
rely on the following aspects:
– the US equipment used (two-di-
mensional US, three-dimensional 
US with volumetric probe or with 
hands-free acquisition);
– the technique adopted (B-mode or 
power Doppler mode or contrast 
agents);
– the scanning protocol followed (sin-
gle standard scan or multiplanar ex-
amination);
– the US material assessed (static im-
ages or video clips);
– the method used to interpret the US 
findings: qualitative (presence or ab-
sence) or quantitative (using a soft-
ware counting the coloured pixels 
located within a region of interest) 
or semiquantitative (3 or 4 degrees).
In order to reach an international con-
sensus, the OMERACT special interest 
group on US is currently developing a 
comprehensive approach for scoring 
both synovitis and bone erosions in 
small joints of patients with RA.
One of the advantages of US is the po-
tential for multiple joint examination 
but such an approach is time consum-
ing and challenges both physicians and 
patients compliance. Which specific 
joints to examine with US remains a 
critical issue to address. There is some 
evidence to suggest that a targeted ap-
proach to US joint examination is com-
parable to a more comprehensive pro-
tocol (14).
Despite US is the most operator depend-
ent modality and the learning curve has 
been defined steep and virtual infinite, 
a training programme specifically de-
signed to acquire the specific compe-
tency required to assess patients with 
RA can speed up the process and put a 
group of motivated rheumatologists in 
a position to scan RA patients accord-
ing to a specific scanning protocol in 
the clinical setting of the early arthritis 
clinics and/or clinical trials.
It seems likely that the pursuit of more 
innovative approaches to US acquisi-
tion will be the subject of consider-
able interest in the future. The most 
promising method is 3D US using a 
volumetric probe which provides auto-
matic acquisition of a virtually infinite 
number of scanning planes lying under 
the footprint. 
This US imaging approach has the po-
tential to rectify the operator depend-
ence of US, simplifying both acquisi-
tion and interpretation of US findings 
especially in the assessment of syno-
vial perfusion using the power Doppler 
(5, 30, 60).
Link
For further ultrasound images, go to: 
www.clinexprheumatol.org/ultrasound
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